Intake disorders: deficiency in spite of a B12-rich diet
Vascular and angiogenic endpoints include: VEGF expression CD34 markers factor VIII markers vascular density endothelial response eNOS signalling NO pathway markers blood flow related tissue response This pathway helps explain why BPC-157 appears in so many different tissue models
At MIHA, we offer an advanced solution that addresses these root causes: the Semaglutide + Cagrilintide combination therapy, a physician-guided treatment designed to support sustainable weight loss, appetite control, and better metabolic function
Available through most functional medicine labs (GI-MAP, Genova GI Effects, or standalone calprotectin through LabCorp/Quest)
Consider a baseline anti-Factor Xa level calibrated for apixaban to establish the patient's baseline anticoagulation intensity
This educational protocol outlines a oncedaily subcutaneous approach using a practical dilution for clear insulinsyringe measurements